Prostate cancer: NICE issues full guidance for Xofigo (radium-223 dichloride)

The National Institute for Health and Care Excellence (NICE) has issued its final guidance recommending Xofigo® (radium-223 dichloride) for use on the NHS in England and Wales as an option for...